By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tekmira Pharmaceuticals Corporation 

100-8900 Glenlyon Parkway

Burnaby  British Columbia  V5J 5J8  Canada
Phone: 604-419-3200 Fax: 604-419-3201



Company News
FDA Modifies Partial Clinical Hold On Tekmira (TKMR)'s TKM-Ebola IND To Allow Multiple Dosing Of Healthy Volunteers 4/10/2015 8:32:08 AM
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015 6:54:31 AM
Tekmira (TKMR) Announces Completion Of Underwritten Public Offering Of Common Shares 3/25/2015 9:49:14 AM
Tekmira (TKMR) Announces Pricing Of Underwritten Public Offering Of Common Shares 3/20/2015 7:23:48 AM
Tekmira (TKMR) Announces Proposed Public Offering Of Common Shares 3/19/2015 7:34:34 AM
Tekmira (TKMR) Strengthens Senior Leadership Team With Key Executive Appointments In Corporate Affairs, Chemistry And Biology 3/18/2015 7:55:30 AM
Tekmira (TKMR) Provides Corporate Update And Announces Year-End 2014 Results 3/13/2015 7:17:49 AM
Tekmira (TKMR)-Ebola-Guinea Enters Phase II Clinical Study In Sierra Leone 3/11/2015 9:47:26 AM
Tekmira (TKMR) To Present At Barclays Global Healthcare Conference 3/9/2015 8:04:32 AM
Tekmira (TKMR) Conference Call And Webcast Advisory: Corporate Update And Full Year 2014 Financial Results 3/6/2015 7:53:02 AM